White House Withdraws Latest Nominee To Head The FDA; HHS Chaos Engine Goes Brrrrrr

Posted

I have said repeatedly that whatever else we can call RFK Jr.’s department of Health and Human Services, it is undoubtedly also a chaos engine. Between nominees who can’t get confirmed, vacant director level positions, other positions being filled by acting directors, and all the rest, HHS is currently producing confusion and incompetence more than anything else. We’ve also seen this at the FDA more specifically, with one chief regulator calling it quits after only three weeks, even though he himself was replacing another regulator who only made it a few months. Further up the chain, you’ll recall that Marty Makary only made it about a year as FDA commissioner before he quit.

In Makary’s place, Kyle Diamantas was named Acting Commissioner in May of this year. He’s still in that role today. The Federal Vacancies Reform Act limits an Acting Commissioner’s ability to serve in that role to 210 days. Diamantas is currently just shy of 200 days in his role to date. And, wouldn’t you know it, the White House has just withdrawn its nominee for FDA Commissioner for reasons nobody seems to totally understand.

The White House withdrew the nomination of Heidi Overton to lead the Food and Drug Administration (FDA) amid opposition from Senate Republicans, it confirmed to The Hill.

Overton was set to face a key vote Wednesday in the Senate health committee, where Republicans hold only a one-vote majority — meaning losing one member would be enough to sink the nomination if all Democrats oppose it.    

The White House said it was pulling the nomination because she didn’t have the votes needed to be confirmed. Strangely, the White House seems to be the only one that thinks that’s true. All that needed to happen was to placate a bunch of anti-abortion GOP senators, which seems like the lowest of hurdles over which the White House needed to leap. Here’s a guy who is routinely fooled by fake promises during confirmation hearings saying so out loud.

Cassidy said he was having “productive conversations” with committee members and believed Overton would have cleared his committee. The final hangup, he said, was anti-abortion senators seeking assurances from the administration about its commitment to “life issues.”

“My conversations with her convinced me she would follow the science and push back against decisions that put Americans’ health at risk,” Cassidy wrote. “The Administration withdrew Dr. Overton rather than make such commitments. Unfortunately, with the limited time left, confirming a permanent FDA Commissioner will fall to Senate Democrats.”

That… doesn’t make a whole lot of sense. The Trump administration has never been shy about bowing to the anti-abortion wing of its own party. For her part, Overton is vehemently anti-abortion. She celebrated when Roe v. Wade was overturned. She refused in confirmation hearings when questioned to admit that mifepristone is medically safe.

This is starting to look instead like the MAHA movement is responsible for this and that it has nothing to do with abortion.

Former Kennedy senior adviser Calley Means, a prominent figure in the MAHA movement, said this month that Overton wrote a policy relaxing standards for fruit-flavored vapes.  

He also alleged Overton helped the Justice Department “construct a legal argument” for why the Supreme Court should take up a case that involved shielding major chemical company Bayer from lawsuits connected to its pesticide products. 

RFK Jr. recently stated that he now has the freedom to go full MAHA with Stephen Miller being named Chief of Staff. This smells for all the world like him, or other MAHA administration creeps, flexing this perceived new muscle and getting the Overton nomination pulled. That is rank speculation, of course, but it makes a great deal more sense than any concerns about abortion from Republican senators.

But, as Cassidy rightly stated, confirming the next FDA Commissioner will fall instead to a Congress controlled by Democrats. There will likely be another Acting Commissioner appointed, since Diamantas’ time will have run out. There won’t be time for new confirmation hearings.

The FDA, like it’s parent agency HHS, is once again outputting chaos.

1, bill cassidy, congress, fda, heidi overton, hhs, kyle diamantas, rfk jr.